These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 17467059)
41. Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder. Hung CI; Wang SJ; Liu CY Depress Anxiety; 2009; 26(6):583-91. PubMed ID: 19242983 [TBL] [Abstract][Full Text] [Related]
42. Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results. Maina G; Rosso G; Bogetto F J Affect Disord; 2009 Apr; 114(1-3):200-7. PubMed ID: 18728001 [TBL] [Abstract][Full Text] [Related]
43. Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy. Bellino S; Zizza M; Rinaldi C; Bogetto F Can J Psychiatry; 2006 Jun; 51(7):453-60. PubMed ID: 16838827 [TBL] [Abstract][Full Text] [Related]
44. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774 [TBL] [Abstract][Full Text] [Related]
45. Do personality traits predict outcome of psychodynamically oriented psychosomatic inpatient treatment beyond initial symptoms? Steinert C; Klein S; Leweke F; Leichsenring F Br J Clin Psychol; 2015 Mar; 54(1):109-25. PubMed ID: 25145630 [TBL] [Abstract][Full Text] [Related]
46. Sleep in major depression: relation to memory performance and outcome after interpersonal psychotherapy. Goder R; Fritzer G; Hinze-Selch D; Huchzermeier C; Koch JM; Seeck-Hirschner M; Aldenhoff JB Neuropsychobiology; 2007; 55(1):36-42. PubMed ID: 17556851 [TBL] [Abstract][Full Text] [Related]
47. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial. Chokka P; Legault M Depress Anxiety; 2008; 25(12):E173-81. PubMed ID: 19006260 [TBL] [Abstract][Full Text] [Related]
48. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder. Amsterdam JD; Shults J; Rutherford N Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135 [TBL] [Abstract][Full Text] [Related]
49. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961 [TBL] [Abstract][Full Text] [Related]
50. Personality self-reports are concurrently reliable and valid during acute depressive episodes. Costa PT; Bagby RM; Herbst JH; McCrae RR J Affect Disord; 2005 Dec; 89(1-3):45-55. PubMed ID: 16203041 [TBL] [Abstract][Full Text] [Related]
51. Patient predictors of response to cognitive behaviour therapy and interpersonal psychotherapy in a randomised clinical trial for depression. Carter JD; Luty SE; McKenzie JM; Mulder RT; Frampton CM; Joyce PR J Affect Disord; 2011 Feb; 128(3):252-61. PubMed ID: 20674982 [TBL] [Abstract][Full Text] [Related]
52. Treatment of an avoidant patient with comorbid psychopathology: a plan analysis perspective. Caspar F; Ecker S J Clin Psychol; 2008 Feb; 64(2):139-53. PubMed ID: 18186111 [TBL] [Abstract][Full Text] [Related]
53. Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER. Reed C; Monz BU; Perahia DG; Gandhi P; Bauer M; Dantchev N; Demyttenaere K; Garcia-Cebrian A; Grassi L; Quail D; Tylee A; Montejo AL J Affect Disord; 2009 Mar; 113(3):296-302. PubMed ID: 18603303 [TBL] [Abstract][Full Text] [Related]
54. Ten month outcome of cognitive behavioural therapy v. interpersonal psychotherapy in patients with major depression: a randomised trial of acute and maintenance psychotherapy. Mulder R; Boden J; Carter J; Luty S; Joyce P Psychol Med; 2017 Oct; 47(14):2540-2547. PubMed ID: 28485261 [TBL] [Abstract][Full Text] [Related]
55. Eighteen months of drug treatment for depression: predicting relapse and recovery. Mulder RT; Frampton CM; Luty SE; Joyce PR J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590 [TBL] [Abstract][Full Text] [Related]
56. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. Dombrovski AY; Lenze EJ; Dew MA; Mulsant BH; Pollock BG; Houck PR; Reynolds CF J Am Geriatr Soc; 2007 Sep; 55(9):1325-32. PubMed ID: 17767673 [TBL] [Abstract][Full Text] [Related]
57. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936 [TBL] [Abstract][Full Text] [Related]
58. Which factors are important predictors of non-recovery from major depression? A 2-year prospective observational study. Viinamäki H; Haatainen K; Honkalampi K; Tanskanen A; Koivumaa-Honkanen H; Antikainen R; Valkonen-Korhonen M; Hintikka J Nord J Psychiatry; 2006; 60(5):410-6. PubMed ID: 17050300 [TBL] [Abstract][Full Text] [Related]
59. Predictors of the response to tricyclic antidepressants in major depression. Popescu C; Ionescu R; Jipescu I Rom J Neurol Psychiatry; 1993; 31(2):117-34. PubMed ID: 8217742 [TBL] [Abstract][Full Text] [Related]
60. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression. Vaccarino AL; Evans KR; Sills TL; Kalali AH Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]